nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—Testosterone Propionate—CYP17A1—melanoma	0.017	0.323	CrCbGaD
Drostanolone—Progesterone—CYP17A1—melanoma	0.0078	0.148	CrCbGaD
Drostanolone—Estradiol—CYP1B1—melanoma	0.00637	0.121	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TP73—melanoma	0.00582	0.00614	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—melanoma	0.00577	0.00609	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.00565	0.00596	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.00557	0.00588	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—AKR1B10—melanoma	0.00551	0.00582	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—melanoma	0.0055	0.00581	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—HDAC2—melanoma	0.00545	0.00575	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—FOXO4—melanoma	0.00545	0.00575	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.00544	0.00574	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—PPARG—melanoma	0.00542	0.00572	CbGpPWpGaD
Drostanolone—Progesterone—CYP1B1—melanoma	0.00541	0.103	CrCbGaD
Drostanolone—AR—Notch-mediated HES/HEY network—HIF1A—melanoma	0.00538	0.00568	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—melanoma	0.00535	0.00564	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—KDR—melanoma	0.00514	0.00543	CbGpPWpGaD
Drostanolone—Testosterone—CYP1B1—melanoma	0.00511	0.0971	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	0.00495	0.00522	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—NOTCH1—melanoma	0.00484	0.00511	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.00458	0.00483	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	0.00441	0.00466	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	0.00441	0.00466	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—RB1—melanoma	0.00438	0.00462	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—melanoma	0.00435	0.00459	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MSH2—melanoma	0.00432	0.00456	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—PPARG—melanoma	0.00428	0.00452	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—melanoma	0.00424	0.00448	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—melanoma	0.00413	0.00436	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—DCC—melanoma	0.00407	0.0043	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—CDKN1B—melanoma	0.00399	0.00421	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	0.00396	0.00418	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—WT1—melanoma	0.00375	0.00396	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—MAPK3—melanoma	0.00374	0.00395	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MSH2—melanoma	0.00371	0.00392	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—melanoma	0.00367	0.00388	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00364	0.00384	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—CD4—melanoma	0.00362	0.00382	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—MAPK3—melanoma	0.00359	0.00379	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—CDKN1B—melanoma	0.00359	0.00379	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CASP8—melanoma	0.00358	0.00378	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—MAPK1—melanoma	0.00356	0.00376	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—AURKA—melanoma	0.00352	0.00372	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.00344	0.00364	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—MAPK1—melanoma	0.00342	0.00361	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—CDKN1B—melanoma	0.00341	0.0036	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—MDM2—melanoma	0.00339	0.00358	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—RAC1—melanoma	0.00336	0.00355	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—MDM2—melanoma	0.00327	0.00345	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.00326	0.00344	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CDKN2A—melanoma	0.00312	0.0033	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—melanoma	0.0031	0.00327	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—PIK3CA—melanoma	0.00309	0.00326	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AURKA—melanoma	0.00303	0.0032	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP17A1—melanoma	0.00289	0.00305	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—HRAS—melanoma	0.00286	0.00301	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP17A1—melanoma	0.00285	0.00301	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—melanoma	0.00285	0.00301	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—STAT3—melanoma	0.00281	0.00296	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—melanoma	0.00274	0.0029	CbGpPWpGaD
Drostanolone—AR—Gene Expression—CLNS1A—melanoma	0.00272	0.00287	CbGpPWpGaD
Drostanolone—Methyltestosterone—ALB—melanoma	0.00265	0.0503	CrCbGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CCND1—melanoma	0.00264	0.00278	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—RB1—melanoma	0.00263	0.00277	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CTNNB1—melanoma	0.00261	0.00276	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—AKT1—melanoma	0.00252	0.00266	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—melanoma	0.00251	0.00265	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL10—melanoma	0.00244	0.00258	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP1B1—melanoma	0.00243	0.00257	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—E2F1—melanoma	0.00243	0.00256	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—AKT1—melanoma	0.00242	0.00256	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP1B1—melanoma	0.0024	0.00253	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—SKI—melanoma	0.00238	0.00251	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—melanoma	0.00228	0.00241	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—MDM2—melanoma	0.00224	0.00236	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.00221	0.00233	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—RAC1—melanoma	0.0022	0.00233	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.00219	0.00231	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.00214	0.00226	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MMP1—melanoma	0.00213	0.00225	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—melanoma	0.00212	0.00224	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—melanoma	0.0021	0.00222	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CDK2—melanoma	0.00209	0.00221	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—E2F1—melanoma	0.00209	0.0022	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—melanoma	0.00206	0.00218	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HIF1A—melanoma	0.00206	0.00217	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.00205	0.00217	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	0.00203	0.00215	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.00201	0.00212	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.00199	0.0021	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—ATM—melanoma	0.00199	0.0021	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CDK4—melanoma	0.00198	0.00209	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.00197	0.00208	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CCND1—melanoma	0.00195	0.00206	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.00193	0.00204	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CTNNB1—melanoma	0.00193	0.00204	CbGpPWpGaD
Drostanolone—Estradiol—ALB—melanoma	0.00192	0.0364	CrCbGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—RAC1—melanoma	0.0019	0.002	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.0019	0.002	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CDKN1A—melanoma	0.00189	0.00199	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—PTEN—melanoma	0.00188	0.00199	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NPPA—melanoma	0.00186	0.00197	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.00186	0.00197	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.00184	0.00194	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MMP1—melanoma	0.00183	0.00194	CbGpPWpGaD
Drostanolone—Estradiol—ABCB1—melanoma	0.00183	0.0347	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.00183	0.00193	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CDK2—melanoma	0.0018	0.0019	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BRAF—melanoma	0.00175	0.00185	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.00173	0.00183	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CASP8—melanoma	0.00173	0.00183	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.00172	0.00182	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—RB1—melanoma	0.00172	0.00182	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CDH1—melanoma	0.00171	0.00181	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—ATM—melanoma	0.00171	0.0018	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—melanoma	0.0017	0.0018	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CDK4—melanoma	0.0017	0.0018	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.00169	0.00178	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—STAT3—melanoma	0.00168	0.00178	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.00165	0.00174	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.00164	0.00173	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ACER3—melanoma	0.00162	0.00171	CbGpPWpGaD
Drostanolone—Progesterone—ABCB1—melanoma	0.00155	0.0295	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.00154	0.00163	CbGpPWpGaD
Drostanolone—Testosterone—ALB—melanoma	0.00154	0.0292	CrCbGaD
Drostanolone—AR—Androgen receptor signaling pathway—EGFR—melanoma	0.00153	0.00161	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.00153	0.00161	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BRAF—melanoma	0.00151	0.00159	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CASP8—melanoma	0.00149	0.00158	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BCL2—melanoma	0.00149	0.00157	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—UGT2B10—melanoma	0.00148	0.00157	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—RB1—melanoma	0.00148	0.00156	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—melanoma	0.00147	0.00156	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—AKT1—melanoma	0.00147	0.00155	CbGpPWpGaD
Drostanolone—Testosterone—ABCB1—melanoma	0.00147	0.0279	CrCbGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MDM2—melanoma	0.00147	0.00155	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00146	0.00155	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.00144	0.00152	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.00141	0.00149	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HS3ST5—melanoma	0.00138	0.00146	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.00137	0.00144	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CXCL8—melanoma	0.00134	0.00141	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CASP3—melanoma	0.00131	0.00139	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.0013	0.00137	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BCL2—melanoma	0.00128	0.00135	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CASP3—melanoma	0.00128	0.00135	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CCND1—melanoma	0.00128	0.00135	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CTNNB1—melanoma	0.00127	0.00134	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—melanoma	0.00126	0.00133	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.00123	0.0013	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—PTEN—melanoma	0.00123	0.0013	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.00123	0.0013	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—NFKB1—melanoma	0.00123	0.0013	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.00122	0.00128	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.0012	0.00126	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NFKB1—melanoma	0.0012	0.00126	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.00117	0.00124	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.00117	0.00123	CbGpPWpGaD
Drostanolone—AR—Gene Expression—RPS3—melanoma	0.00116	0.00123	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SNRPE—melanoma	0.00115	0.00121	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SKI—melanoma	0.00115	0.00121	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—melanoma	0.00113	0.00119	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—VEGFA—melanoma	0.00111	0.00118	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00111	0.00117	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.00111	0.00117	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—melanoma	0.0011	0.00116	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—melanoma	0.00109	0.00115	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—CDKN2B—melanoma	0.00109	0.00115	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.00109	0.00115	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—VEGFA—melanoma	0.00109	0.00115	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—AKT1—melanoma	0.00108	0.00114	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—VDR—melanoma	0.00106	0.00112	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—melanoma	0.00106	0.00112	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.00106	0.00112	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—melanoma	0.00106	0.00111	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.00105	0.00111	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PLCB4—melanoma	0.00104	0.0011	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00103	0.00108	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MYC—melanoma	0.00102	0.00108	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.00102	0.00108	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.00102	0.00108	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.00102	0.00107	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.001	0.00106	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—EGFR—melanoma	0.001	0.00106	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC6A11—melanoma	0.000982	0.00104	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIP4K2A—melanoma	0.000982	0.00104	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—melanoma	0.000958	0.00101	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MTAP—melanoma	0.000956	0.00101	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—KRAS—melanoma	0.000947	0.000999	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000934	0.000986	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TNF—melanoma	0.00093	0.000982	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000923	0.000974	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NPPA—melanoma	0.000897	0.000947	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MYC—melanoma	0.000882	0.000931	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000873	0.000921	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.000863	0.00091	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—melanoma	0.000862	0.00091	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PHGDH—melanoma	0.000852	0.000899	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—LUM—melanoma	0.000852	0.000899	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000849	0.000896	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—TP53—melanoma	0.000841	0.000888	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HPSE—melanoma	0.000835	0.000882	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000831	0.000877	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.00083	0.000877	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CUBN—melanoma	0.00082	0.000865	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—melanoma	0.000815	0.00086	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SDHD—melanoma	0.000792	0.000836	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CSPG4—melanoma	0.000792	0.000836	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—BSG—melanoma	0.000792	0.000836	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000791	0.000835	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000785	0.000828	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NOTCH1—melanoma	0.000784	0.000827	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GPAM—melanoma	0.000767	0.000809	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL6—melanoma	0.00075	0.000792	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—PPARG—melanoma	0.00074	0.000781	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—TP53—melanoma	0.000724	0.000764	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000721	0.000761	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000711	0.00075	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000697	0.000736	CbGpPWpGaD
Drostanolone—AR—Gene Expression—HDAC2—melanoma	0.000656	0.000692	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PLA2G6—melanoma	0.000652	0.000688	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000611	0.000645	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000589	0.000622	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—VCAN—melanoma	0.000586	0.000618	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000554	0.000585	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000535	0.000565	CbGpPWpGaD
Drostanolone—AR—Gene Expression—CDKN2B—melanoma	0.000524	0.000553	CbGpPWpGaD
Drostanolone—AR—Gene Expression—VDR—melanoma	0.000511	0.000539	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP17A1—melanoma	0.000494	0.000522	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000487	0.000514	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000481	0.000508	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PRKCA—melanoma	0.000471	0.000497	CbGpPWpGaD
Drostanolone—AR—Gene Expression—ERCC2—melanoma	0.000467	0.000493	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GNA11—melanoma	0.000467	0.000493	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—FASN—melanoma	0.000457	0.000482	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC5A5—melanoma	0.000449	0.000474	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GNAQ—melanoma	0.000434	0.000458	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CD44—melanoma	0.000434	0.000458	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000425	0.000448	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—MYC—melanoma	0.000422	0.000445	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000421	0.000444	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP1B1—melanoma	0.000416	0.000439	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NOTCH1—melanoma	0.000377	0.000398	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000367	0.000387	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PPARG—melanoma	0.000356	0.000376	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ABCB1—melanoma	0.000343	0.000362	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PRKCA—melanoma	0.000315	0.000333	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ERCC2—melanoma	0.000313	0.00033	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000259	0.000273	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CG—melanoma	0.000247	0.000261	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPARG—melanoma	0.000238	0.000252	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CD—melanoma	0.000217	0.000229	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ALB—melanoma	0.000214	0.000226	CbGpPWpGaD
Drostanolone—AR—Gene Expression—MAPK3—melanoma	0.000209	0.00022	CbGpPWpGaD
Drostanolone—AR—Gene Expression—MYC—melanoma	0.000203	0.000214	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CB—melanoma	0.000189	0.0002	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTGS2—melanoma	0.000187	0.000198	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTEN—melanoma	0.000163	0.000173	CbGpPWpGaD
Drostanolone—AR—Gene Expression—AKT1—melanoma	0.000141	0.000149	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CA—melanoma	0.000115	0.000122	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKT1—melanoma	9.42e-05	9.95e-05	CbGpPWpGaD
